Bellevue Group Ag Myovant Sciences Ltd. Transaction History

Bellevue Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $48,060 - $54,040	-2,000 Reduced 0.03%	5,910,639 $159 Million
Q3 2022 Nov 14, 2022	SELL	$11.6 - $20.44 $81,200 - $143,080	-7,000 Reduced 0.12%	5,912,639 $106 Million
Q2 2022 Aug 11, 2022	BUY	$7.78 - $14.69 $471,468 - $890,214	60,600 Added 1.03%	5,919,639 $73.6 Million
Q1 2022 May 13, 2022	SELL	$11.38 - $16.4 $3.53 Million - $5.08 Million	-310,000 Reduced 5.03%	5,859,039 $78 Million
Q4 2021 Feb 10, 2022	BUY	$14.31 - $23.87 $5.72 Million - $9.55 Million	400,000 Added 6.93%	6,169,039 $96.1 Million
Q3 2021 Nov 12, 2021	BUY	$18.94 - $26.99 $9.47 Million - $13.5 Million	500,000 Added 9.49%	5,769,039 $129 Million
Q2 2021 Aug 12, 2021	BUY	$17.07 - $24.56 $1.28 Million - $1.84 Million	75,000 Added 1.44%	5,269,039 $120 Million
Q1 2021 May 12, 2021	BUY	$20.46 - $25.18 $7.98 Million - $9.82 Million	390,000 Added 8.12%	5,194,039 $107 Million
Q4 2020 Feb 16, 2021	SELL	$13.8 - $27.62 $3.97 Million - $7.95 Million	-287,961 Reduced 5.66%	4,804,039 $133 Million
Q3 2020 Nov 16, 2020	BUY	$14.05 - $22.6 $6.25 Million - $10.1 Million	445,000 Added 9.58%	5,092,000 $71.5 Million
Q2 2020 Aug 13, 2020	SELL	$7.34 - $20.84 $1.23 Million - $3.5 Million	-168,109 Reduced 3.49%	4,647,000 $95.8 Million
Q3 2019 Nov 14, 2019	BUY	$5.19 - $9.46 $4.7 Million - $8.56 Million	905,000 Added 23.15%	4,815,109 $25 Million
Q2 2019 Aug 14, 2019	BUY	$8.69 - $25.0 $34 Million - $97.8 Million	3,910,109 New	3,910,109 $35.4 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.